Analysis of the insulin-like growth factor 1 receptor gene in children born small for gestational age: in vitro characterization of a novel mutation (p.Arg511Trp)
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
Citação
CLINICAL ENDOCRINOLOGY, v.78, n.4, p.558-563, 2013
Resumo
Background Insulin-like growth factor 1 insensitivity caused by IGF1R mutations has been previously identified as one of the causes of growth impairment in children born small for gestational age (SGA). Objective To analyse the IGF1R in children born SGA. Subjects From an initial cohort of 54 sequential children born SGA, without catch-up growth, 25 children were selected for this IGF1R study due to the presence of serum IGF-1 values above the mean for their age and sex. Methods The proximal IGF1R promoter region, the entire coding region and the exonintron boundaries were directly sequenced, and multiplex ligation-dependent probe amplification analysis was performed. Fibroblast cultures were developed from one patient with a mutation for the in vitro characterization of IGF-1 insensitivity. Results The copy number variation analysis did not identify deletions involving the IGF1R gene. We identified two children carrying heterozygous nucleotide substitutions in IGF1R: c.16G>A/p.Gly6Arg and c.1531C>T/p.Arg511Trp. The first variant (p.Gly6Arg) was identified in control subjects (0 center dot 3%) and in a relative with normal growth; thus, it was considered to be a rare benign allelic variation. The second variant (p.Arg511Trp) was not found in 306 alleles from control subjects, and it segregated with the growth impairment phenotype in the patient's family. Fibroblasts obtained from this patient had a significantly reduced proliferative response and AKT phosphorylation after IGF-1 stimulation compared with control fibroblasts. Conclusion The identification of an inactivating IGF1R mutation in the present cohort should encourage further studies of larger series to establish the precise frequency of this molecular defect in children with growth impairment of a prenatal onset.
Palavras-chave
Referências
- Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107
- Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744
- Clayton PE, 2007, J CLIN ENDOCR METAB, V92, P804, DOI 10.1210/jc.2006-2017
- Coutinho DC, 2007, J CLIN ENDOCR METAB, V92, P4889, DOI 10.1210/jc.2007-1661
- DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0
- Ester WA, 2009, J CLIN ENDOCR METAB, V94, P4717, DOI 10.1210/jc.2008-1502
- Fang P, 2012, J CLIN ENDOCR METAB, V97, pE243, DOI 10.1210/jc.2011-2142
- Fang P, 2009, J CLIN ENDOCR METAB, V94, P1740, DOI 10.1210/jc.2008-1903
- Inagaki K, 2007, J CLIN ENDOCR METAB, V92, P1542, DOI 10.1210/jc.2006-2354
- Kawashima Y, 2005, J CLIN ENDOCR METAB, V90, P4679, DOI 10.1210/jc.2004-1947
- Kawashima Y, 2012, CLIN ENDOCRINOL, V77, P246, DOI 10.1111/j.1365-2265.2012.04357.x
- Kruis T, 2010, J CLIN ENDOCR METAB, V95, P1137, DOI 10.1210/jc.2009-1433
- Leal AD, 2011, ARQ BRAS ENDOCRINOL, V55, P541, DOI 10.1590/S0004-27302011000800007
- Mohn A, 2011, HORM RES PAEDIAT, V76, P136, DOI 10.1159/000324957
- Montenegro LR, 2012, EUR J ENDOCRINOL, V166, P543, DOI 10.1530/EJE-11-0964
- Raile K, 2006, J CLIN ENDOCR METAB, V91, P2264, DOI 10.1210/jc.2005-2146
- Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
- TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3
- TANNER JM, 1966, ARCH DIS CHILD, V41, P454
- Walenkamp MJE, 2006, J CLIN ENDOCR METAB, V91, P3062, DOI 10.1210/jc.2005-1597
- Wallborn T, 2010, J CLIN ENDOCR METAB, V95, P2316, DOI 10.1210/jc.2009-2404
- Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805